174 related articles for article (PubMed ID: 38529351)
21. ERS International Congress 2023: highlights from the Paediatrics Assembly.
Vijverberg SJH; Kampouras A; Nayir Büyükşahin H; Makrinioti H; Petrarca L; Schmidt M; Schreck LD; Urbantat RM; Beydon N; Goutaki M; Lavizzari A; Proesmans M; Schramm D; Stahl M; Zacharasiewicz A; Moeller A; Pijnenburg MW
ERJ Open Res; 2024 Jan; 10(1):. PubMed ID: 38410713
[TBL] [Abstract][Full Text] [Related]
22. Spectrum of interstitial lung diseases at a tertiary center in a developing country: A study of 803 subjects.
Dhooria S; Agarwal R; Sehgal IS; Prasad KT; Garg M; Bal A; Aggarwal AN; Behera D
PLoS One; 2018; 13(2):e0191938. PubMed ID: 29420550
[TBL] [Abstract][Full Text] [Related]
23. ERS International Congress 2023: highlights from the Sleep Disordered Breathing Assembly.
Siciliano M; Bradicich M; Tondo P; Gunduz Gurkan C; Kuczyński W; Martini A; Aydin Güçlü Ö; Testelmans D; Sánchez-de-la-Torre M; Randerath W; Schwarz EI; Schiza S
ERJ Open Res; 2024 Mar; 10(2):. PubMed ID: 38529349
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs).
Spagnolo P; Distler O; Ryerson CJ; Tzouvelekis A; Lee JS; Bonella F; Bouros D; Hoffmann-Vold AM; Crestani B; Matteson EL
Ann Rheum Dis; 2021 Feb; 80(2):143-150. PubMed ID: 33037004
[TBL] [Abstract][Full Text] [Related]
25. ERS International Congress, Madrid, 2019: highlights from the Pulmonary Vascular Diseases Assembly.
Ramjug S; Weatherald J; Sahay S; Khoury J; Foris V; Chandran N; Bokan A; Godinas L; Delcroix M
ERJ Open Res; 2020 Oct; 6(4):. PubMed ID: 33083438
[TBL] [Abstract][Full Text] [Related]
26. [Update in interstitial lung disease 2023].
Huang H
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):44-49. PubMed ID: 38062694
[TBL] [Abstract][Full Text] [Related]
27. Progressive Fibrosing Interstitial Lung Diseases: A Current Perspective.
Albera C; Verri G; Sciarrone F; Sitia E; Mangiapia M; Solidoro P
Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572422
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence.
Richeldi L; Varone F; Bergna M; de Andrade J; Falk J; Hallowell R; Jouneau S; Kondoh Y; Morrow L; Randerath W; Strek M; Tabaj G
Eur Respir Rev; 2018 Dec; 27(150):. PubMed ID: 30578333
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms and management of cough in interstitial lung disease.
Rasheed AZ; Metersky ML; Ghazal F
Expert Rev Respir Med; 2023 Dec; 17(12):1177-1190. PubMed ID: 38159067
[TBL] [Abstract][Full Text] [Related]
30. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.
Makino S
Mod Rheumatol; 2021 Jan; 31(1):13-19. PubMed ID: 32964766
[TBL] [Abstract][Full Text] [Related]
31. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
Lamb YN
Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
[TBL] [Abstract][Full Text] [Related]
32. ERS International Congress 2022: highlights from the Thoracic Surgery and Lung Transplantation Assembly.
Magouliotis DE; Bos S; Esendagli D; Nardini M; Migliore M; Perch M; Cardillo G; Meloni F; Ricciardi S; Hellemons M
ERJ Open Res; 2023 Mar; 9(2):. PubMed ID: 37077552
[TBL] [Abstract][Full Text] [Related]
33. ERS International Congress 2023: highlights from the Basic and Translational Sciences Assembly.
Reddy KD; Bizymi N; Schweikert A; Ananth S; Lim CX; Lodge KM; Joannes A; Ubags N; van der Does AM; Cloonan SM; Mailleux A; Mansouri N; Reynaert NL; Heijink IH; Cuevas-Ocaña S
ERJ Open Res; 2024 Mar; 10(2):. PubMed ID: 38686182
[TBL] [Abstract][Full Text] [Related]
34. ERS International Congress 2021: highlights from the Respiratory Infections Assembly.
Meldrum OW; Belchamber KBR; Chichirelo-Konstantynovych KD; Horton KL; Konstantynovych TV; Long MB; McDonnell MJ; Perea L; Garcia-Basteiro AL; Loebinger MR; Duarte R; Keir HR
ERJ Open Res; 2022 Apr; 8(2):. PubMed ID: 35615420
[TBL] [Abstract][Full Text] [Related]
35. Highlights from the ERS International Congress 2018: Assembly 13 - Pulmonary Vascular Diseases.
Ramjug S; Adão R; Lewis R; Coste F; de Man F; Jimenez D; Sitbon O; Delcroix M; Vonk-Noordegraaf A
ERJ Open Res; 2019 Feb; 5(1):. PubMed ID: 30895188
[TBL] [Abstract][Full Text] [Related]
36. Bronchoalveolar Lavage Fluid Characteristics of Patients With Sarcoidosis and Nonsarcoidosis Interstitial Lung Diseases: Ten-Year Experience of a Single Center in Turkey.
Tanriverdi H; Erboy F; Altinsoy B; Uygur F; Arasli M; Ozel Tekin I; Tor MM; Atalay F
Iran Red Crescent Med J; 2015 Oct; 17(10):e31103. PubMed ID: 26566455
[TBL] [Abstract][Full Text] [Related]
37. Clinical highlights from the 2011 ERS Congress in Amsterdam.
Spruit MA; Chavannes NH; Herth FJ; Poletti V; Ley S; Burghuber OC; Clini E; Cottin V
Eur Respir J; 2012 Jun; 39(6):1501-10. PubMed ID: 22408196
[TBL] [Abstract][Full Text] [Related]
38. Mass cytometry identifies characteristic immune cell subsets in bronchoalveolar lavage fluid from interstitial lung diseases.
Hata K; Yanagihara T; Matsubara K; Kunimura K; Suzuki K; Tsubouchi K; Eto D; Ando H; Uehara M; Ikegame S; Baba Y; Fukui Y; Okamoto I
Front Immunol; 2023; 14():1145814. PubMed ID: 36949950
[TBL] [Abstract][Full Text] [Related]
39. Clinical highlights from the 2016 European Respiratory Society International Congress.
Kahn N; Fregonese L; Barrecheguren M; Franssen FME; Grgic A; Gompelmann D; Bibaki E; Antoniou KM; Kocks JWH; Pinnock H; Herth F
ERJ Open Res; 2017 Apr; 3(2):. PubMed ID: 28462234
[TBL] [Abstract][Full Text] [Related]
40. ERS International Congress 2022: highlights from the Respiratory Infections Assembly.
Banka R; Chichirelo-Konstantynovych K; Horton KL; Konstantynovych T; Long MB; McDonnell MJ; Meldrum OW; Park M; Perea L; Viltsaniuk O; Keir HR
ERJ Open Res; 2023 May; 9(3):. PubMed ID: 37228292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
